These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18301972)

  • 1. IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women.
    Liu JM; Zhao HY; Ning G; Chen Y; Zhang LZ; Sun LH; Zhao YJ; Xu MY; Chen JL
    J Bone Miner Metab; 2008; 26(2):159-64. PubMed ID: 18301972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic osteoporosis in premenopausal women.
    Rubin MR; Schussheim DH; Kulak CA; Kurland ES; Rosen CJ; Bilezikian JP; Shane E
    Osteoporos Int; 2005 May; 16(5):526-33. PubMed ID: 15300364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women.
    Zhao HY; Liu JM; Ning G; Zhao YJ; Chen Y; Sun LH; Zhang LZ; Xu MY; Chen JL
    Osteoporos Int; 2008 Feb; 19(2):221-6. PubMed ID: 17703270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An independent positive relationship between the serum total osteocalcin level and fat-free mass in healthy premenopausal women.
    Liu JM; Zhao HY; Zhao L; Chen Y; Zhang LZ; Tao B; Sun LH; Zhao YJ; Wang WQ; Xu MY; Chen JL; Ning G
    J Clin Endocrinol Metab; 2013 May; 98(5):2146-52. PubMed ID: 23553865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
    Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.
    Kim JG; Shin CS; Choi YM; Moon SY; Kim SY; Lee JY
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis.
    Jiang LS; Zhang ZM; Jiang SD; Chen WH; Dai LY
    J Bone Miner Res; 2008 Apr; 23(4):475-83. PubMed ID: 18052758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.
    Scacchi M; Danesi L; Cattaneo A; Sciortino G; Radin R; Ambrogio AG; Vitale G; D'Angelo E; Mirra N; Zanaboni L; Arvigo M; Boschetti M; Ferone D; Marzullo P; Baldini M; Cassinerio E; Cappellini MD; Persani L; Cavagnini F
    Endocrine; 2016 Aug; 53(2):551-7. PubMed ID: 26825070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K in combination with other biochemical markers to diagnose osteoporosis.
    Heiss C; Hoesel LM; Wehr U; Keller T; Horas U; Meyer C; Rambeck W; Schnettler R
    Biomarkers; 2004; 9(6):479-88. PubMed ID: 15849068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women.
    Martini G; Valenti R; Giovani S; Franci B; Campagna S; Nuti R
    Bone; 2001 Jan; 28(1):113-7. PubMed ID: 11165951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis.
    Piatek S; Adolf D; Wex T; Halangk W; Klose S; Westphal S; Amthauer H; Winckler S
    Maturitas; 2013 Apr; 74(4):363-8. PubMed ID: 23391500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
    Ahn SH; Kim JH; Cho YY; Suh S; Kim BJ; Hong S; Lee SH; Koh JM; Song KH
    Osteoporos Int; 2019 May; 30(5):1059-1069. PubMed ID: 30719548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis.
    Koh JM; Khang YH; Jung CH; Bae S; Kim DJ; Chung YE; Kim GS
    Osteoporos Int; 2005 Oct; 16(10):1263-71. PubMed ID: 15702263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women: a population-based study.
    Nabipour I; Larijani B; Beigi S; Jafari SM; Amiri M; Assadi M; Pazoki R; Amiri Z; Sanjdideh Z
    Menopause; 2008; 15(5):934-9. PubMed ID: 18451743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
    Gorai I; Taguchi Y; Chaki O; Nakayama M; Minaguchi H
    Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of insulin-like growth factor-1 and leptin on bone mineral content in healthy premenopausal women.
    Jürimäe J; Jürimäe T
    Exp Biol Med (Maywood); 2006 Nov; 231(10):1673-7. PubMed ID: 17060689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of bisphenol A (BPA) exposure on fat mass and serum leptin concentrations have no impact on bone mineral densities in non-obese premenopausal women.
    Zhao HY; Bi YF; Ma LY; Zhao L; Wang TG; Zhang LZ; Tao B; Sun LH; Zhao YJ; Wang WQ; Li XY; Xu MY; Chen JL; Ning G; Liu JM
    Clin Biochem; 2012 Dec; 45(18):1602-6. PubMed ID: 22981830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.
    Cohen A; Recker RR; Lappe J; Dempster DW; Cremers S; McMahon DJ; Stein EM; Fleischer J; Rosen CJ; Rogers H; Staron RB; Lemaster J; Shane E
    Osteoporos Int; 2012 Jan; 23(1):171-82. PubMed ID: 21365462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between adiponectin, leptin, insulin growth factor-1 and bone mineral density in pre and postmenopausal women.
    Morcov C; Vulpoi C; Brănişteanu D
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):785-9. PubMed ID: 23272528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation.
    Avbersek-Luznik I; Gmeiner Stopar T; Marc J
    Clin Chem Lab Med; 2007; 45(8):1014-8. PubMed ID: 17579570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.